Across TCGA pan-cancer cohorts, PAXIP1-AS2 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated PAXIP1-AS2 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher PAXIP1-AS2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PAXIP1-AS2 expression acts as an unfavorable survival marker.

COAD are the cancer types where PAXIP1-AS2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.113	0.806	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: PAXIP1-AS2 tumor-vs-normal RNA expression · all PAXIP1-AS2 data types